SEC Form 4 · accession 0002024911-26-000004
BIO-RAD LABORATORIES, INC. · BIO BIO.B
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eva Anette Engelhardt
Officer — EVP, President, CDG
Period of report
Jul 25, 2026
Accepted (ET)
Jul 28, 2026 · 3:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000012208
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Bio-Rad A Common StockF1 | Jul 25, 2026 | M | 246 | $0.00 | A | 592 | D | |
| Bio-Rad A Common Stock | Jul 25, 2026 | F | 89 | $314.46 | D | 503 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F3 | $0.00 | Jul 25, 2026 | M | 246 | D | — | — | Bio-Rad A Common Stock | 246 | 492 | D |
Explanation of responses
- F1Shares of Class A common stock acquired on the vesting of restricted stock units.
- F2Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
- F3The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.